Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026.
Saved in:
| Title: | Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026. |
|---|---|
| Authors: | Lucaccioni H; Epiconcept, Paris, France.; These authors contributed equally to this work and share first authorship., Marques DF; Epiconcept, Paris, France.; These authors contributed equally to this work and share first authorship., Kirsebom F; UK Health Security Agency, London, United Kingdom., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen Denmark., Hamilton M; Public Health Scotland, Glasgow, United Kingdom., Whitaker H; UK Health Security Agency, London, United Kingdom., Bolt Botnen A; Department of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark., Bucholc M; Public Health Agency, Belfast, United Kingdom., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Andrews N; UK Health Security Agency, London, United Kingdom., Trebbien R; Department of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark., Hameed SS; Public Health Scotland, Glasgow, United Kingdom., Lauenborg Møller K; Data Integration and Analyses, Statens Serum Institut, Copenhagen, Denmark., O'Doherty MG; Public Health Agency, Belfast, United Kingdom., Lopez-Bernal J; UK Health Security Agency, London, United Kingdom., Morrison K; Public Health Scotland, Glasgow, United Kingdom., Cottrell S; Public Health Wales, Cardiff, United Kingdom., Wilton S; Public Health Agency, Belfast, United Kingdom., Rose AM; Epiconcept, Paris, France.; These authors contributed equally to this work and share last authorship., Kissling E; Epiconcept, Paris, France.; These authors contributed equally to this work and share last authorship. |
| Corporate Authors: | European IVE group; The members of the network are listed under Collaborators. |
| Source: | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2026 Feb; Vol. 31 (7). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
